Emeritus Professor
Pamela Russell
Administrative Division,
Human Resources,
Office of the VP (People) & Chief People Officer
Biography
Prof Russell joined the Australian Prostate Cancer Research Centre - Queensland (APCRC–Q) in 2009 where she holds the position of Professor, Head of Biomedical Imaging and Prostate Cancer Models. Prof Russell is a member of the Institute of Health and Biomedical Innovation, Queensland University of Technology working in translational studies in prostate cancer. Her current work focuses on the development of new animal models to study bony metastasis from prostate cancer. Prof Russell also investigates the development of theranostics, - nanotechnology for real time imaging for diagnosis and therapeutic delivery, including gene therapy of prostate cancer, and finding biomarkers from exosomes to predict treatment response in patients undergoing therapy. Prof Russell trained in immunology at Walter & Eliza Hall Institute, where she obtained an MSc with Sir Macfarlane Burnet and a PhD with Sir Gustav Nossal, on studies of autoimmune diseases. She then trained at John Curtin School of Medical Research, Canberra, and at Kolling Institute of Medical Research. In 1984, Prof Russell changed her research focus to cancer and, with Dr Derek Raghavan, established the Urological Cancer Research Centre at Royal Prince Alfred Hospital/University of Sydney. Prof Russell then directed the Oncology Research Centre (ORC), Prince of Wales Hospital from 1992 to 2010, as conjoint Professor of Medicine, University of New South Wales (UNSW). Prof Russell has built an international reputation for work on bladder and prostate cancer, with expertise for establishing cell lines and rare xenografts from primary human tumours. She collaborates widely, within Australia and overseas in USA and Europe. She has supervised several postgraduate students, and since 2008 she has delivered presentations or chaired sessions at 14 international prostate cancer meetings. Nationally, she helped to initiate the Australian Genitourinary Oncology Group and the Prostate Cancer Foundation of Australia (PCFA) (of which she is a life member). From 2007 to 2010 Prof Russell served as an inaugural Director/Secretary of the Australasian Urological and Prostate Cancer Clinical Trials Group (ANZUP). She is also an Australian editor for Urological Research and a member of Movember’s Global Scientific Committee. Prof Russell has been on peer review committees for the National Health and Medical Research Committee (NHMRC), Cancer Council Australia, Cure Cancer Australia, and regularly reviews papers from international journals.Research theme: Health
Research discipline: Cell and Molecular Biosciences
Personal details
Positions
- Emeritus Professor
Administrative Division,
Human Resources,
Office of the VP (People) & Chief People Officer
Keywords
bony metastasis, gene therapy, imaging using nanoparticles, prostate cancer, prostate cancer animal models
Research field
Biochemistry and Cell Biology, Microbiology, Other Biological Sciences
Field of Research code, Australian and New Zealand Standard Research Classification (ANZSRC), 2008
Qualifications
- PhD (The University of Melbourne)
Professional memberships and associations
Membership of Professional Societies
Current
Member of Australian Society for Immunology
Current
Associate member of American Association for Cancer Research
Current
Member of Clinical Oncology Society of Australia Current
Founding Member, Genitourinary Cancer Urological Group
1998-1999
Vice-Chairman, Genitourinary Cancer Urological Group
Current
Urological Society of Australasia: Associate Member
Current
Gene Therapy group of NSW now Australian Society for Gene Therapy
1998
Executive Member, Australian Society for Gene Therapy
2007-2010
Secretary and Director, ANZUP Australian and New Zealand Prostate and Urological Cancer Clinical Trials Group Ltd
Leadership in Professional Societies and Associations
1977-1978
Qualifications Committee of the Austrlaian Society of Microbiology
1979
Education Officer of the Australian society of Microbiology for ACT
1991
Member of Research Committee of COSA
1993
Founding member of Genitourinary Oncology Group GUOG
1995-1996
Secretary, GUOG 1998-1999 Vice-Chairman, GUOG
1998
Executive, Gene Therapy Group, NSW
1998-2000
Board Member, Prostate Cancer Research Foundation
2002-
Member of Bioresource Committee, APCC
2004-
Executive Member, APCC
2002-2004
Member of Board of Management of Biological Resources Centre (BRC), UNSW
2004-2006
Member of Advisory Committee of Biological Resources (BRAAG), UNSW
2004-
Member of IP Committee, St Vincents Hospital, Sydney
2003-2006
Member of Cancer Care Committee, South Eastern Sydney Area Health Service
2005-2006
Executive member, Scientific steering Committee, Prostate Cancer Foundation of Australia
2006-
Executive Member, Urological Oncology Program, NSW Cancer Institute
2007-2010
Secretary, Director, Australian Prostate and Urological Cancer Clinical Trials Group, ANZUP
Publications
QUT ePrints
For more publications by Pamela, explore their research in QUT ePrints (our digital repository).
Selected research projects
- Title
- Immuno-Polymeric Drugs for Prostate Cancer Therapy
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- 1099321
- Start year
- 2016
- Keywords
- Title
- The Microniche: A Novel In-vitro and In-vivo Prostate Cancer Model System
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- 1108043
- Start year
- 2016
- Keywords
- Prostate Cancer; Metastatic Cancer; Bone Marrow; Stem Cell Biology; Hormone-refractory Prostate Cancer
- Title
- Next Generation Hybrid Nanomaterials: Bispecific Antibody-Targeted Polymers
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- LP150100703
- Start year
- 2015
- Keywords
- Title
- Novel prostate cancer target for diagnosis, imaging, detection of recurrence and response to therapy
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- 1093539
- Start year
- 2015
- Keywords
- Diagnostic; Gcp1; Imaging Agent; Prostate Cancer; Therapy
- Title
- Imaging Prostate Cancer Theranostics
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- 1046831
- Start year
- 2013
- Keywords
- imaging; prostate cancer; diagnosis; drug delivery; cancer staging
- Title
- Simultaneous Imaging and Drug Delivery for Prostate Cancer Theranostics
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- NDDA 0411
- Start year
- 2012
- Keywords
- 19f-Mri; Targeted Drug Delivery; Drug Conjugated Hyperbranched Polymers; Prostate Cancer Imaging; Theranostics
- Title
- To Identify a New Therapeutic Target for the Treatment of Prostate Cancer
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- 1031228
- Start year
- 2012
- Keywords
- prostate cancer; invasion; epithelial-mesenchymal transition (EMT); protein kinases; targeted therapy
- Title
- To Study how Prostate Tumor Metastasizes to Bone
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- 1031221
- Start year
- 2012
- Keywords
- Prostate Cancer; Bone Metastasis; Stem Cells; Microrna; Epithelial-mesenchymal Transition (EMT)
- Title
- KLK4 is a Master Regulator of Tumour Microenvironment Remodelling in Prostate Cancer and Bone Metastasis
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- 1010141
- Start year
- 2011
- Keywords
- Kallikrein; Prostate Cancer; KLK4; PROTOMAP; 3D Gell Matrices; TAILS
- Title
- Evaluation of the Therapeutic Potential of SFTI-FCQR, a Novel Kallikrein 4-Specific Protease Inhibitor
- Primary fund type
- CAT 1 - Australian Competitive Grant
- Project ID
- 497270
- Start year
- 2008
- Keywords
- Ovarian Cancer; Prostate Cancer; Androgens; Kallikreins; Protease Inhibitors
Projects listed above are funded by Australian Competitive Grants. Projects funded from other sources are not listed due to confidentiality agreements.